| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 97,15 | 97,35 | 28.01. | |
| 97,05 | 97,45 | 28.01. |
| Stück | Geld | Kurs | Brief | Stück |
|---|---|---|---|---|
| 103,90 | 50 | |||
| 103,50 | 60 | |||
| 102,70 | 15 | |||
| 102,50 | 400 | |||
| 102,00 | 8 | |||
| 101,00 | 168 | |||
| 100,50 | 20 | |||
| 100,00 | 108 | |||
| 99,00 | 100 | |||
| 97,15 | 85 | |||
Quelle: [URL] https://aktienkurs-orderbuch.finanznachrichten.de/22ua.htm [/URL] | ||||
| 10 | 96,80 | |||
| 85 | 96,15 | |||
| 100 | 96,00 | |||
| 100 | 95,90 | |||
| 20 | 95,10 | |||
| 289 | 95,00 | |||
| 90 | 94,80 | |||
| 160 | 93,70 | |||
| 100 | 93,00 | |||
| 14 | 92,65 | |||
| Summe Aktien im Kauf | Verhältnis | Summe Aktien im Verkauf | ||
| 968 | 1,048 | 1.014 | ||
| Uhrzeit | Aktienkurs | Stück |
|---|---|---|
| 17:35:45 | 96,85 | 1.366 |
| 17:28:30 | 96,55 | 37 |
| 17:27:00 | 96,50 | 41 |
| 17:26:48 | 96,55 | 58 |
| 17:26:48 | 96,55 | 65 |
| 17:24:16 | 96,45 | 3 |
| 17:24:08 | 96,55 | 56 |
| 17:23:26 | 96,50 | 215 |
| 17:21:04 | 96,55 | 87 |
| 17:21:04 | 96,55 | 16 |
| 17:21:04 | 96,65 | 67 |
| 17:21:04 | 96,55 | 54 |
| 17:20:01 | 96,65 | 5 |
| 17:20:00 | 96,58 | 7 |
| 17:19:17 | 96,55 | 103 |
| 17:19:13 | 96,55 | 98 |
| 17:19:13 | 96,60 | 2 |
| 17:19:04 | 96,60 | 100 |
| 17:19:04 | 96,65 | 103 |
| 17:18:54 | 96,75 | 88 |
| Tagesumsatz Xetra | -3,35 -3,34 % | 37.049 |
Angaben in grüner Schrift zeigen, dass der Aktienkurs im Vergleich zum vorherigen Kurs gestiegen ist. Angaben in roter Schrift zeigen gefallene Börsenkurse.
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Panik-Modus bei Biontech? Diese Signale machen Anleger nervös | Hebelschein-Spekulant | |||
| Mi | Eilmeldung am Abend: BIONTECH SE ADR stürzt brutal ab! | 92 | Maximilian Berger | ||
| BIONTECH Aktie jetzt für 0€ handeln | |||||
| Mi | BioNTech SE (BNTX): A Bull Case Theory | 92 | Insider Monkey | ||
| Mi | BioNTech ernennt Kylie Jimenez zur Chief People Officer | 363 | 4investors | Der Aufsichtsrat der BioNTech SE hat Kylie Jimenez mit Wirkung zum 1. März 2026 zur neuen Chief People Officer (Chief People Officer) ernannt. Die neu geschaffene Vorstandsposition umfasst die Verantwortung... ► Artikel lesen | |
| Mi | BioNTech SE - 6-K, Report of foreign issuer | 71 | SEC Filings |
| Zeit | Aktuelle Nachrichten | Medien | ||
|---|---|---|---|---|
| Mi | Ensysce Biosciences Provides Enrollment Update on Pivotal Phase 3 Trial of PF614, Its Next-Generation Opioid for Severe Acute Pain | ACCESS Newswire | ~ Engineered to Deliver Potent Pain Relief with Built-In Abuse Protection ~ SAN DIEGO, CA / ACCESS Newswire / January 28, 2026 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company")... ► Artikel lesen | |
| 00:24 | GenSight Biologics S.A.: GenSight Biologics Announces the Results of its Extraordinary General Meeting of January 28, 2026 | Business Wire | Regulatory News:
GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal... ► Artikel lesen | |
| Mi | NurExone ebnet den Weg für klinischen Start von ExoPTEN | Small- & Micro Cap Investment | ||
| Mi | Morning Market Movers: Murano Global Investments, Flora Growth, Kustom Entertainment, Ainos See Big Swings | AFX News | OTTAWA (dpa-AFX) - At 7:20 a.m. ET on Wednesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| Mi | Defence Therapeutics Inc.: Defence Therapeutics Expands Collaboration with Canadian Nuclear Laboratories to Accelerate Its Proprietary Radiopharmaceutical Pipeline | Newsfile | Montreal, Quebec--(Newsfile Corp. - January 28, 2026) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a publicly traded biotechnology and precision... ► Artikel lesen |